4//SEC Filing
Coelho Mary Theresa 4
Accession 0001103021-21-000002
CIK 0001103021other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:30 PM ET
Size
9.2 KB
Accession
0001103021-21-000002
Insider Transaction Report
Form 4
Coelho Mary Theresa
See Remarks
Transactions
- Sale
Common Stock
2021-01-19$4.32/sh−6,462$27,916→ 23,889 total - Exercise/Conversion
Restricted Stock Units
2021-01-15−18,333→ 18,334 totalExercise: $0.00From: 2020-01-15Exp: 2022-01-17→ Common Stock (18,333 underlying) - Exercise/Conversion
Common Stock
2021-01-15+18,333→ 30,351 total
Footnotes (3)
- [F1]The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan.
- [F2]On January 19, 2021, the Reporting Person sold an aggregate of 6,462 shares of the Issuer's Common Stock at a weighted average price of $4.32 per share. The highest sale price for the Common Stock was $4.34 per share and the lowest sale price was $4.32 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
- [F3]The shares of common stock were acquired by the Reporting Person as a result of the vesting of 18,333 Restricted Stock Units ("RSUs") granted to the Reporting Person on January 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended. The remainder of the RSUs under this grant vest on January 15, 2022.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001720772
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:30 PM ET
- Size
- 9.2 KB